| Neuroinflammation in animal models of traumatic brain injury CC Chiu, YE Liao, LY Yang, JY Wang, D Tweedie, HK Karnati, NH Greig, ... Journal of neuroscience methods 272, 38-49, 2016 | 289 | 2016 |
| Utility of neuronal-derived exosomes to examine molecular mechanisms that affect motor function in patients with Parkinson disease: a secondary analysis of the exenatide-PD trial D Athauda, S Gulyani, H kumar Karnati, Y Li, D Tweedie, M Mustapic, ... JAMA neurology 76 (4), 420-429, 2019 | 194 | 2019 |
| miRNAs: key players in neurodegenerative disorders and epilepsy HK Karnati, MK Panigrahi, RK Gutti, NH Greig, IA Tamargo Journal of Alzheimer's Disease 48 (3), 563-580, 2015 | 128 | 2015 |
| Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease B Ray, B Maloney, K Sambamurti, HK Karnati, PT Nelson, NH Greig, ... Translational psychiatry 10 (1), 47, 2020 | 69 | 2020 |
| TLR-4 signalling pathway: MyD88 independent pathway up-regulation in chicken breeds upon LPS treatment HK Karnati, SR Pasupuleti, R Kandi, RB Undi, I Sahu, TR Kannaki, ... Veterinary research communications 39, 73-78, 2015 | 58 | 2015 |
| Neuronal enriched extracellular vesicle proteins as biomarkers for traumatic brain injury HK Karnati, JH Garcia, D Tweedie, RE Becker, D Kapogiannis, NH Greig Journal of Neurotrauma 36 (7), 975-987, 2019 | 53 | 2019 |
| Adiponectin as a potential therapeutic target for prostate cancer HK Karnati, MK Panigrahi, Y Li, D Tweedie, NH Greig Current pharmaceutical design 23 (28), 4170-4179, 2017 | 42 | 2017 |
| Therapeutic potential of siRNA and DNAzymes in cancer HK Karnati, RS Yalagala, R Undi, SR Pasupuleti, RK Gutti Tumor biology 35, 9505-9521, 2014 | 40 | 2014 |
| Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury D Tweedie, HK Karnati, R Mullins, CG Pick, BJ Hoffer, EJ Goetzl, ... Elife 9, e55827, 2020 | 32 | 2020 |
| Down regulated expression of Claudin-1 and Claudin-5 and up regulation of β-catenin: association with human glioma progression H K Karnati, M Panigrahi, N A Shaik, N H Greig, AR Bagadi, M A Kamal, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 32 | 2014 |
| microRNAs: key players in hematopoiesis HK Karnati, S Raghuwanshi, S Sarvothaman, U Gutti, RGV Saladi, ... microRNA: Basic Science: From Molecular Biology to Clinical Practice, 171-211, 2015 | 12 | 2015 |
| Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondaly Analysis of the Exenatide-PD … D Athauda, S Gulyani, HK Karnati JAMA NEUROLOGY 76 (4), 509-509, 2019 | 5 | 2019 |
| Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease B Ray, B Maloney, K Sambamurti, HK Karnati, PT Nelson, NH Greig, ... Translational Psychiatry 10, 2020 | 2 | 2020 |
| Exenatide Modulates Neuronal Insulin Signalling in Parkinson’s Disease (S27. 002) D Athauda, S Gulyani, H Karnati, Y Li, D Tweedie, S Skene, K Chowdhury, ... Neurology 90 (15 Supplement), 2018 | | 2018 |
| Exenatide Modulates Neuronal Insulin Signalling in Parkinson’s Disease S Gulyani, H Karnati, Y Li, D Tweedie, S SKENE, K Chowdhury, ... Neurology 90 (15), 2018 | | 2018 |
| Extracellular vesicle biomarkers predict response to experimental treatment in a clinical trial in Parkinson's disease D Kapogiannis, D Athauda, S Gulyani, H Karnati, N Greig, T Foltynie Journal of Extracellular Vesicles 7, 199-199, 2018 | | 2018 |
Dimitrios KapogiannisNational Institute on Aging (NIA/NIH)Підтверджена електронна адреса в mail.nih.gov
